Cape Biologix
@capebiologix.com
Cape Biologix Technologies develops and manufactures plant-made, recombinant monoclonal proteins. We use our plants as single-use, biodegradable bioreactors to produce pharmaceutically relevant proteins for multiple uses across diagnostics, vaccines, or therapeutic applications. As you might have noticed, we LOVE plants. We love them so much in fact that we're on a mission to use plant biotechnology to improve the well-being of people, animals, and plants 💚 Feel free to reach out to us if you're like to connect.
Cape Biologix's Company Logos
Cape Biologix's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#35224C
Port Gore
53, 34, 76
267, 38, 22
30, 55, 0, 70
#00B7CD
Robin's Egg Blue
0, 183, 205
186, 100, 40
100, 11, 0, 20
#F78DA7
Persian Pink
247, 141, 167
345, 87, 76
0, 43, 32, 3
About Cape Biologix
Cape Biologix Technologies, based in Cape Town, is a dynamic brand that specializes in utilizing plant-based expression platforms to enhance the health and well-being of both humans and animals. Established in 2020, our mission is to contribute to global biosecurity by manufacturing high-quality, accessible, and cost-effective plant-based proteins. Our transient plant-based expression platform sets us apart from traditional expression platforms, offering superior speed, quality, flexibility, scalability, and sustainability.
As a subsidiary of Cape Bio Pharms, we are fortunate to have strategic partners around the world supporting our endeavors. Since our establishment in 2022, Cape Biologix Technologies has quickly become a pioneer in plant-made recombinant protein manufacture, expanding our facilities and catalog of plant-made recombinant proteins. Over the years, we have successfully developed more than 40 proof of concept plant-based proteins and launched a suite of SARS-CoV-2 proteins to the market for use in lateral flow test kits.
With a team of highly experienced industry leaders, including our CEO Kobus Lindeque, Executive Chair Belinda Shaw, CFO Lynn Scheel, and Scientific Advisor Prof. Edward Rybicki, Cape Biologix Technologies is dedicated to revolutionizing the biotechnology industry. Explore our range of plant-based recombinant proteins for research and diagnostic applications and experience the innovative solutions we offer
Company type
Privately Held
Year founded
2020
Company size
11-50 employees
